Clinical Trial Update: Comparative Study of Two Recombinant Human Erythropoietin Products in Chronic Kidney Disease Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is comparing two recombinant human erythropoietin products in patients with anemia of chronic kidney disease; the study is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• Recombinant human erythropoietin product A
• Recombinant human erythropoietin product B

Snippet

Sponsor: Megalabs | Conditions: Anemia of Chronic Kidney Disease | Phase 3 | Status: NOT_YET_RECRUITING